巨子生物:根据一般授权配售现有股份及补足认购新股份 募资约23亿港元

格隆汇
17 Apr

格隆汇4月17日丨巨子生物(02367.HK)发布公告,2025年4月16日,公司、补足卖方(即Juzi Holding Co., Ltd)及联席账簿管理人(即高盛、中金公司及汇丰)订立配售及认购协议,据此,(i)补足卖方已同意出售,而联席账簿管理人个别同意作为补足卖方代理尽最大努力促使承配人按每股66.65港元的价格购买补足卖方所持有的3500万股股份,及(ii)补足卖方有条件同意认购,而公司有...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10